Emmanuel Kwaku Ofori (PhD) is currently an Associate Professor and the Head of the Department of Chemical Pathology at the University of Ghana Medical School. He obtained his PhD in July 2018 from the University of Lausanne in Switzerland. He teaches several disciplines in the health sciences (medical, nursing, veterinary, and laboratory sciences, amongst others). He has supervised and mentored many undergraduate and postgraduate students. His research focuses on lipidomics, metabolic medicine, and steroidal adaptations to diet and exercise. He aims to become an international expert on translational research into metabolic diseases. He has about 68 publications to his credit. He has also presented several abstracts at global conferences. He is the Academic Editor for PLOS One and the Journal of Diabetes Research (John Wiley). Seth Kwabena Amponsah (PhD) is an Associate Professor of Medical Pharmacology at the University of Ghana Medical School. He has held postdoctoral fellowships under the AQ1 BANGA-Africa Project and BSU III (DANIDA, Denmark). He has over 13 years of experience in teaching and research. His research focuses on clinical pharmacology (infectious disease and antimicrobial stewardship): prudent use of antimicrobials, antimicrobial level monitoring, and efficacy of antimicrobials in patients. He has experience in population pharmacokinetic modelling, noncompartment pharmacokinetic estimation, and pharmacokinetic evaluation of new drug formulations. He has published over 60 research articles, 3 books, 20 book chapters, and several conference abstracts. He is an Academic Editor for PLOS One and an Associate Editor for Pan African Medical Journal.

• 1. Recent updates and the state of the art of renal biochemistry2. Renal biomarkers: Diagnostic precision, prognostic implications and therapeutic interventions3. Role of big data and artificial intelligence in renal disease diagnosis and treatment4. Approaches to proteinuria and nephrotic syndrome: The intricate landscape of integrative genomics and micro RNAs5. Nutritional derailments and management of nephrotic syndrome6. Hepatorenal syndrome: current insights and future perspectives7. Minimal change disease: Current trends and therapeutic options8. Antihelminthic drugs and glomerulonephritis9. Current technological approaches to the utility of omics (metabolomics, lipidomics, genomics, and transcriptomics) in renal diseases diagnosis, prognosis, and treatment10. Kidney disease and complementary medicine11. Fanconi syndrome: New perspectives and preventive strategies12. Lipid mediators in genitourinary impairment: Current developments and future perspectives13. Renal Osteodystrophy: New developments and challenges14. Renal manifestations of systemic lipus erythrematosis in pediatrics15. Insights into chronic renal disease: Lessons from animal models16. Renal manifestations and diabetes mellitus: The missing link17. Precision medicine in nephrology: Challenges and future directions

Emmanuel Kwaku Ofori (PhD) is currently an Associate Professor and the Head of the Department of Chemical Pathology at the University of Ghana Medical School. He obtained his PhD in July 2018 from the University of Lausanne in Switzerland. He teaches several disciplines in the health sciences (medical, nursing, veterinary, and laboratory sciences, amongst others). He has supervised and mentored many undergraduate and postgraduate students. His research focuses on lipidomics, metabolic medicine, and steroidal adaptations to diet and exercise. He aims to become an international expert on translational research into metabolic diseases. He has about 68 publications to his credit. He has also presented several abstracts at global conferences. He is the Academic Editor for PLOS One and the Journal of Diabetes Research (John Wiley). Seth Kwabena Amponsah (PhD) is an Associate Professor of Medical Pharmacology at the University of Ghana Medical School. He has held postdoctoral fellowships under the AQ1 BANGA-Africa Project and BSU III (DANIDA, Denmark). He has over 13 years of experience in teaching and research. His research focuses on clinical pharmacology (infectious disease and antimicrobial stewardship): prudent use of antimicrobials, antimicrobial level monitoring, and efficacy of antimicrobials in patients. He has experience in population pharmacokinetic modelling, noncompartment pharmacokinetic estimation, and pharmacokinetic evaluation of new drug formulations. He has published over 60 research articles, 3 books, 20 book chapters, and several conference abstracts. He is an Academic Editor for PLOS One and an Associate Editor for Pan African Medical Journal.

• 1. Recent updates and the state of the art of renal biochemistry2. Renal biomarkers: Diagnostic precision, prognostic implications and therapeutic interventions3. Role of big data and artificial intelligence in renal disease diagnosis and treatment4. Approaches to proteinuria and nephrotic syndrome: The intricate landscape of integrative genomics and micro RNAs5. Nutritional derailments and management of nephrotic syndrome6. Hepatorenal syndrome: current insights and future perspectives7. Minimal change disease: Current trends and therapeutic options8. Antihelminthic drugs and glomerulonephritis9. Current technological approaches to the utility of omics (metabolomics, lipidomics, genomics, and transcriptomics) in renal diseases diagnosis, prognosis, and treatment10. Kidney disease and complementary medicine11. Fanconi syndrome: New perspectives and preventive strategies12. Lipid mediators in genitourinary impairment: Current developments and future perspectives13. Renal Osteodystrophy: New developments and challenges14. Renal manifestations of systemic lipus erythrematosis in pediatrics15. Insights into chronic renal disease: Lessons from animal models16. Renal manifestations and diabetes mellitus: The missing link17. Precision medicine in nephrology: Challenges and future directions

Emmanuel Kwaku Ofori (PhD) is currently an Associate Professor and the Head of the Department of Chemical Pathology at the University of Ghana Medical School. He obtained his PhD in July 2018 from the University of Lausanne in Switzerland. He teaches several disciplines in the health sciences (medical, nursing, veterinary, and laboratory sciences, amongst others). He has supervised and mentored many undergraduate and postgraduate students. His research focuses on lipidomics, metabolic medicine, and steroidal adaptations to diet and exercise. He aims to become an international expert on translational research into metabolic diseases. He has about 68 publications to his credit. He has also presented several abstracts at global conferences. He is the Academic Editor for PLOS One and the Journal of Diabetes Research (John Wiley). Seth Kwabena Amponsah (PhD) is an Associate Professor of Medical Pharmacology at the University of Ghana Medical School. He has held postdoctoral fellowships under the AQ1 BANGA-Africa Project and BSU III (DANIDA, Denmark). He has over 13 years of experience in teaching and research. His research focuses on clinical pharmacology (infectious disease and antimicrobial stewardship): prudent use of antimicrobials, antimicrobial level monitoring, and efficacy of antimicrobials in patients. He has experience in population pharmacokinetic modelling, noncompartment pharmacokinetic estimation, and pharmacokinetic evaluation of new drug formulations. He has published over 60 research articles, 3 books, 20 book chapters, and several conference abstracts. He is an Academic Editor for PLOS One and an Associate Editor for Pan African Medical Journal.

• 1. Recent updates and the state of the art of renal biochemistry2. Renal biomarkers: Diagnostic precision, prognostic implications and therapeutic interventions3. Role of big data and artificial intelligence in renal disease diagnosis and treatment4. Approaches to proteinuria and nephrotic syndrome: The intricate landscape of integrative genomics and micro RNAs5. Nutritional derailments and management of nephrotic syndrome6. Hepatorenal syndrome: current insights and future perspectives7. Minimal change disease: Current trends and therapeutic options8. Antihelminthic drugs and glomerulonephritis9. Current technological approaches to the utility of omics (metabolomics, lipidomics, genomics, and transcriptomics) in renal diseases diagnosis, prognosis, and treatment10. Kidney disease and complementary medicine11. Fanconi syndrome: New perspectives and preventive strategies12. Lipid mediators in genitourinary impairment: Current developments and future perspectives13. Renal Osteodystrophy: New developments and challenges14. Renal manifestations of systemic lipus erythrematosis in pediatrics15. Insights into chronic renal disease: Lessons from animal models16. Renal manifestations and diabetes mellitus: The missing link17. Precision medicine in nephrology: Challenges and future directions